We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Fracture Risk Predicted with New Genetic Screen

By LabMedica International staff writers
Posted on 09 Aug 2018
Low bone mineral density (BMD) is the major determinant for osteopenia and osteoporosis, which increase the chances of fragility fracture especially for elderly women. More...
Low BMD is also a risk factor for bone fractures, especially stress fracture.

Early identification of people with an increased genetic risk for osteoporosis could be an important way to prevent or reduce the incidence of bone fracture, which according to the National Osteoporosis Foundation affects two million people each year and accounts for USD 19 billion in annual health care costs.

A scientist at Stanford University Medical Center (Stanford, CA, USA) analyzed the genetic data and health information of nearly 400,000 people in the UK Biobank, a vast compendium of de-identified information freely available to public health scientists around the world. For each participant, data on bone-mineral density, age, height, weight and sex, as well that participant's genome sequence was collected. A computer algorithm to identify naturally occurring genetic differences among people found with low bone-mineral density was developed.

Using the algorithm, the scientist was able to identify 1,362 independent differences, or single-nucleotide polymorphisms (SNPs), that correlated with low bone-mineral density readings. The resulting algorithm assigned a score to each of the nearly 400,000 participants to indicate their risk of low bone-mineral density; subsequent analyses showed that those in the bottom 2.2% of these scores were 17 times more likely than their peers to have been diagnosed with osteoporosis and nearly twice as likely to have experienced a bone fracture. A total of 1,362 independent SNPs were identified with a genome-wide significant association to estimated bone mineral density (eBMD). These SNPs clustered into 899 loci, of which 286 were previously identified and 613 are new.

Stuart K. Kim, PhD, an emeritus professor and sole author of the study, said, “Fifteen million people in this country have already accessed their genome sequences using direct-to-consumer testing services. I think this analysis has the potential to become the standard of care in the coming years. It would be a relatively simple measure to identify those who should have their bone-mineral density tested and perhaps take steps at an early age to ensure their future bone health.” The study was published on July 26, 2018, in the journal PLOS ONE.

Related Links:
Stanford University Medical Center


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.